Glycopyrrolate + Indacaterol Suppliers & Bulk Manufacturers

Available Forms: Inhalation powder delivered via Neohaler device/Breezhaler device

Available Strengths: Ultibro Breezhaler: Indacaterol 85 mcg + Glycopyrronium 43 mcg

Reference Brands: Utibron Neohaler(Dis.cntd in US-2020); Ultibro Breezhaler(EU)

Category: Respiratory Disorder

Glycopyrrolate + Indacaterol is a dual bronchodilator used for long-term COPD management. It combines a LAMA and LABA to improve breathing and reduce symptoms. Sold as Ultibro Breezhaler in the EU, it offers once-daily relief and better lung function, but is not for acute symptom relief. Glycopyrrolate + Indacaterol is available in Inhalation powder delivered via Neohaler device/Breezhaler device and strengths such as Ultibro Breezhaler: Indacaterol 85 mcg + Glycopyrronium 43 mcg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Glycopyrrolate + Indacaterol is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Glycopyrrolate + Indacaterol can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Glycopyrrolate + Indacaterol is a dual bronchodilator combination used for the long-term maintenance treatment of chronic obstructive pulmonary disease (COPD). Glycopyrrolate is a long-acting muscarinic antagonist (LAMA), while Indacaterol is a long-acting beta2-agonist (LABA). Together, they provide effective, once-daily bronchodilation, improving lung function and reducing COPD symptoms like breathlessness. Marketed under brand names such as Ultibro Breezhaler in the EU and previously as Utibron Neohaler in the US, this inhalation therapy offers enhanced respiratory relief. It is not intended for acute symptom relief but plays a vital role in COPD management by optimizing airflow and improving patients’ quality of life.